泌尿外科医生执业附属与前列腺癌调强放疗在老年患者中的应用
该回顾性队列研究纳入2010至2012年确诊前列腺癌的Medicare受益人,评估泌尿外科医生执业类型及放疗设施所有权与调强放疗(IMRT)使用的关系。结果显示,拥有IMRT所有权的单一专科组患者接受IMRT的比例高于无所有权的单一专科组(43% vs 30%,p<0.001),在非癌死亡风险>75%的患者中同样如此(42% vs 26%,p<0.001)。
要点
- 拥有放疗设施所有权的泌尿外科组IMRT使用率为43%,无所有权组为30%(p<0.001)。
- 非癌死亡风险>75%的患者中,有所有权组IMRT使用42% vs 无所有权组26%(p<0.001)。
- 非癌死亡风险>75%的患者中,有所有权组总体治疗53% vs 无所有权组44%(p<0.001)。
核心结论
- 在拥有放疗所有权利益的单一专科组执业的泌尿外科医生更可能治疗前列腺癌患者,包括非癌死亡高风险患者。
研究设计与样本
- 回顾性队列研究,纳入2010至2012年确诊前列腺癌的Medicare受益人。
- 按泌尿外科医生执业附属(单一专科组按规模、多学科组)及放疗设施所有权分类。
- 使用广义估计方程调整患者差异。
主要发现
- 新诊断前列腺癌患者中,IMRT使用率从多学科组的24%到大泌尿外科组的37%(p<0.001)。
- 有IMRT所有权的组(n=5133)患者接受IMRT的比例高于无所有权的单一专科组(43% vs 30%,p<0.001),与组规模无关。
- 非癌死亡风险>75%的患者中,有所有权组IMRT使用率42% vs 无所有权组26%(p<0.001),总体治疗率53% vs 44%(p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prostate cancer treatment is a significant source of morbidity and spending. Some men with prostate cancer, particularly those with significant health problems, are unlikely to benefit from treatment. OBJECTIVE: To assess relationships between financial incentives associated with urologist ownership of radiation facilities and treatment for prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort of Medicare beneficiaries with prostate cancer diagnosed between 2010 and 2012. Patients were further classified by their risk of dying from noncancer causes in the 10 yr following their cancer diagnosis by using a mortality model derived from comparable patients known to be cancer-free. INTERVENTION: Urologists were categorized by their practice affiliation (single-specialty groups by size, multispecialty group) and ownership of a radiation facility. OUTCOME MEASUREMENTS AND ANALYSIS: Use of intensity-modulated radiation therapy (IMRT) and use of any treatment within 1 yr of diagnosis. Generalized estimating equations were used to adjust for patient differences. RESULTS: Among men with newly diagnosed prostate cancer, use of IMRT ranged from 24% in multispecialty groups to 37% in large urology groups (p<0.001). Patients managed in groups with IMRT ownership (n=5133) were more likely to receive IMRT than those managed by single-specialty groups without ownership (43% vs 30%, p<0.001), regardless of group size. Among patients with a very high risk (> 75%) of noncancer mortality within 10 yr of diagnosis, both IMRT use (42% vs 26%, p<0.001) and overall treatment (53% vs 44%, p<0.001) were more likely in groups with ownership than in those without, respectively. CONCLUSIONS: Urologists practicing in single-specialty groups with an ownership interest in radiation therapy are more likely to treat men with prostate cancer, including those with a high risk of noncancer mortality. PATIENT SUMMARY: We assessed treatment for prostate cancer among urologists with varying levels of financial incentives favoring intervention. Those with stronger incentives, as determined by ownership interest in a radiation facility, were more likely to treat prostate cancer, even when treatment was unlikely to provide a survival benefit to the patient.
引用
- Hollenbeck BK, Kaufman SR, Yan P, et al. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. Eur Urol. 2017. PMID: 28823605. doi:10.1016/j.eururo.2017.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。